US 10660968
Spirocyclic degronimers for target protein degradation
granted A61KA61K31/435A61K31/438
Quick answer
US patent 10660968 (Spirocyclic degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K47/545, A61K47/554